European Archives - Page 979 of 1137 - European Medical Journal

Type 2 Diabetes Mellitus: Beyond the Beta Cell

Type 2 diabetes mellitus (T2DM) currently affects >8% of the world population. It is the leading cause of blindness, end-stage kidney disease, and…

Editor’s Pick: New Drugs for Type 2 Diabetes: New Hopes and New Concerns About the Skeleton

There is growing evidence indicating the effects of medications for Type 2 diabetes mellitus (T2DM) on bone metabolism and fracture risk.

Treatment of Type 2 Diabetes with Biphasic Insulin Analogues

The majority of patients with Type 2 diabetes require insulin therapy for treating hyperglycaemia. There are several regimens available for insulin…

Utility of Glycated Haemoglobin in Gestational Diabetes Mellitus: Present and Future

Gestational diabetes mellitus (GDM) is a major public health problem with various complexities involved in its diagnosis. Traditionally an oral glucose…

Treatment Strategies for Chorioretinal Vascular Diseases: Advantages and Disadvantages of Individualised Therapy

Chorioretinal vascular diseases are among the leading causes of blindness in industrialised countries. The recent development and widespread adoption of…

Anti-Hyperglycaemic and Lipid Profile Regulatory Properties of Moringa Oleifera in Subjects at Early Stages of Type 2 Diabetes Mellitus

Moringa oleifera leaf powder (MOLP) was incorporated into patient diets in order to study its effects on the levels of fasting blood glucose (FBG)…

EMJ

Congress Review – EASD 2016

Read our congress review in our EMJ Diabetes 4.1 2016 eJournal, available now…

EMJ

An interview with Prof Dr Coen Stehouwer at the 2016 EASD Congress

An interview with Prof Dr Coen Stehouwer (Professor of Medicine and Chair, Department of Internal Medicine) at the 2016 EASD Congress, Munich, Germany.

EMJ

An interview with Prof Vilma Urbančič-Rovan at the 2016 EASD Congress

An interview with Prof Vilma Urbančič-Rovan (Head of the Diabetes Unit, University Medical Centre Ljubljana) at the 2016 EASD Congress, Munich, Germany.

An interview with Prof Chris Griffiths at the 2016 EADV Congress

An interview with Prof Chris Griffiths (Professor of Dermatology, University of Manchester) at the 2016 EADV Congress, Vienna, Austria.